Evidence map›Paper›PMID 39692400›Full record

ReviewJournal of breast imaging2025

Current Concepts in Molecular Breast Imaging.

Miral M Patel, Beatriz E Adrada, Mary S Guirguis, Gary Whitman, Tanya W Moseley, Gaiane M Rauch

Abstract readReview
In one paragraph

Review in Journal of breast imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Miral M PatelDepartment of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-0942-2731
Beatriz E AdradaDepartment of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-5539-5332
Mary S GuirguisDepartment of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gary WhitmanDepartment of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Tanya W MoseleyDepartment of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-2018-8253
Gaiane M RauchDepartment of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

Molecular breast imaging (MBI) is a functional imaging modality that utilizes technetium 99m sestamibi radiotracer uptake to evaluate the biology of breast tumors. Molecular breast imaging can be a useful tool for supplemental screening of women with dense breasts, for breast cancer diagnosis and staging, and for evaluation of treatment response in patients with breast cancer undergoing neoadjuvant systemic therapy. In addition, MBI is useful in problem-solving when mammography and US imaging are insufficient to arrive at a definite diagnosis and for patients who cannot undergo breast MRI. Based on the BI-RADS lexicon, a standardized lexicon has been developed to aid radiologists in MBI reporting. In this article, we review MBI equipment, procedures, and lexicon; clinical indications for MBI; and the radiation dose associated with MBI.

Indexed as

Breast NeoplasmsMolecular ImagingBreastFemaleHumansRadiopharmaceuticalsTechnetium Tc 99m SestamibiRadiopharmaceuticalsTechnetium Tc 99m Sestamibibreast cancer screeningbreast cancer stagingbreast-specific gamma imagingmolecular breast imagingTc-99m sestamibi

Identifiers

PMID39692400
PMCPMC11918265

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.